Bioorganic & Medicinal Chemistry

• 

  Publication Venue For

  • Design, synthesis and evaluation of ¹⁵ N- and ¹³ C-labeled molecular probes as hyperpolarized nitric oxide sensors..  72:116969. 2022
  • Modifying aroylhydrazone prochelators for hydrolytic stability and improved cytoprotection against oxidative stress..  26:5962-5972. 2018
  • Synthesis and biological evaluation of largazole zinc-binding group analogs..  25:3077-3086. 2017
  • Selection of heptapeptides that bind helix 69 of bacterial 23S ribosomal RNA..  21:1240-1247. 2013
  • Studies on the biosynthesis of the lipodepsipeptide antibiotic Ramoplanin A2..  20:859-865. 2012
  • Directed evolution of a pyruvate aldolase to recognize a long chain acyl substrate..  19:6447-6453. 2011
  • Probing of the cis-5-phenyl proline scaffold as a platform for the synthesis of mechanism-based inhibitors of the Staphylococcus aureus sortase SrtA isoform..  17:2886-2893. 2009
  • A small molecule inhibitor of alpha4 integrin-dependent cell migration..  17:977-980. 2009
  • Synthesis, dopaminergic profile, and molecular dynamics calculations of N-aralkyl substituted 2-aminoindans..  16:3233-3244. 2008
  • Characterization and crystal structure of Escherichia coli KDPGal aldolase..  16:710-720. 2008
  • Design and synthesis of manganese porphyrins with tailored lipophilicity: investigation of redox properties and superoxide dismutase activity..  15:7066-7086. 2007
  • A kit method for the high level synthesis of [211At]MABG..  15:3430-3436. 2007
  • Transformation of mu-opioid receptor agonists into biologically potent mu-opioid receptor antagonists..  15:1237-1251. 2007
  • Mechanism of the Class I KDPG aldolase..  14:3002-3010. 2006
  • Synthesis and anti-HIV activity of bi-functional betulinic acid derivatives..  14:2279-2289. 2006
  • O6-3-[125I]iodobenzyl-2'-deoxyguanosine ([125I]IBdG): synthesis and evaluation of its usefulness as an agent for quantification of alkylguanine-DNA alkyltransferase (AGT)..  13:3889-3898. 2005
  • A bacterial selection for the directed evolution of pyruvate aldolases..  12:4067-4074. 2004
  • Inhibition of the Staphylococcus aureus sortase transpeptidase SrtA by phosphinic peptidomimetics..  12:3723-3729. 2004
  • Meta-iodobenzylguanidine derivatives containing a second guanidine moiety..  12:1649-1656. 2004
  • Cytotoxic and antimalarial constituents from the roots of Eurycoma longifolia..  12:537-544. 2004
  • The alkaloids and other constituents from the root and stem of Aristolochia elegans..  12:439-446. 2004
  • Cloning, isolation and characterization of the Thermotoga maritima KDPG aldolase..  10:545-550. 2002
  • Radiosynthesis of 5-(2-(4-pyridinyl)vinyl)-6-chloro-3-(1-[(11)C]methyl-2-(S)-pyrrolidinylmethoxy)pyridine, a high affinity ligand for studying nicotinic acetylcholine receptors by positron emission tomography..  9:3055-3058. 2001
  • Conformational considerations in the design of dual antagonists of platelet-activating factor (PAF) and histamine..  7:1413-1423. 1999
  • Synthesis of isomeric 3-piperidinyl and 3-pyrrolidinyl benzo[5,6]cyclohepta[1,2-b]pyridines: sulfonamido derivatives as inhibitors of Ras prenylation..  6:673-686. 1998
  • Anti-AIDS agents--XXVII. Synthesis and anti-HIV activity of betulinic acid and dihydrobetulinic acid derivatives..  5:2133-2143. 1997
  • Conformational studies of dithymidine boranomonophosphate diastereoisomers..  5:787-795. 1997
  • C2-symmetrical tetrahydroxyazepanes as inhibitors of glycosidases and HIV/FIV proteases..  4:2055-2069. 1996
  • Analysis of the binding specificities of oligomannoside-binding proteins using methylated monosaccharides..  4:1963-1977. 1996
  • Suksdorfin: an anti-HIV principle from Lomatium suksdorfii, its structure-activity correlation with related coumarins, and synergistic effects with anti-AIDS nucleosides..  2:1051-1056. 1994